These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12423822

  • 1. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization.
    Collinet P, Subtil D, Puech F, Vaast P.
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1102-5. PubMed ID: 12423822
    [Abstract] [Full Text] [Related]

  • 2. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC, Lopriore E, Zwiers C, Böhringer S, Janssen MWM, Oepkes D, De Haas M.
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [Abstract] [Full Text] [Related]

  • 3. Severe Rh alloimmunization and hemolytic disease of the fetus managed with plasmapheresis, intravenous immunoglobulin and intrauterine transfusion: A case report.
    Houston BL, Govia R, Abou-Setta AM, Reid GJ, Hadfield M, Menard C, Noyd J, Main S, Zarychanski R.
    Transfus Apher Sci; 2015 Dec; 53(3):399-402. PubMed ID: 26321100
    [Abstract] [Full Text] [Related]

  • 4. Kell hemolytic disease of the fetus. Combination treatment with plasmapheresis and intrauterine blood transfusion.
    Lakhwani S, Machado P, Pecos P, Coloma M, Rebollo S, Raya JM.
    Transfus Apher Sci; 2011 Aug; 45(1):9-11. PubMed ID: 21723196
    [Abstract] [Full Text] [Related]

  • 5. Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.
    Al Riyami AZ, Al Salmani M, Al Hashami S, Al Mahrooqi S, Al Hinai S, Al Balushi H, Al Riyami N, Gowri V, Al Dughaishi T, Al Hosni S, Al-Khabori M, Al-Farsi K, Al Huneini M, Alkindi S.
    Transfusion; 2014 Jan; 54(1):238-43. PubMed ID: 23829228
    [Abstract] [Full Text] [Related]

  • 6. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC, Ramos-Corpas D, Oyonarte S, Montoya F.
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [Abstract] [Full Text] [Related]

  • 7. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ, Klumper FJ, de Haas M, Meerman RH, van Kamp IL, Oepkes D.
    Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
    [Abstract] [Full Text] [Related]

  • 8. Intraperitoneal and intracardiac transfusion of recurrent fetal erythroblastosis due to anti-M alloimmunization with unfavorable outcome.
    Lin TH, Shih JC, Lin CH, Lin SY, Su YN, Lee CN.
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):253-5. PubMed ID: 22795103
    [Abstract] [Full Text] [Related]

  • 9. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC, Moise KJ, Klein KL, Tint H, Castillo B, Bai Y.
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [Abstract] [Full Text] [Related]

  • 10. Serial blood donations for intrauterine transfusions of severe hemolytic disease of the newborn with the use of recombinant erythropoietin in a pregnant woman alloimmunized with anti-Ku.
    Lydaki E, Nikoloudi I, Kaminopetros P, Bolonaki I, Sifakis S, Kikidi K, Koumantakis E, Foundouli K.
    Transfusion; 2005 Nov; 45(11):1791-5. PubMed ID: 16271105
    [Abstract] [Full Text] [Related]

  • 11. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C, van der Bom JG, van Kamp IL, van Geloven N, Lopriore E, Smoleniec J, Devlieger R, Sim PE, Ledingham MA, Tiblad E, Moise KJ, Gloning KP, Kilby MD, Overton TG, Jørgensen DS, Schou KV, Paek B, Walker M, Parry E, Oepkes D, de Haas M.
    Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [Abstract] [Full Text] [Related]

  • 12. [Kell alloimmunization in pregnancy].
    Gariod S, Brossard Y, Poissonnier MH, Vuilliez B, Deutsch V, Jouk PS, Pons JC.
    J Gynecol Obstet Biol Reprod (Paris); 2004 Nov; 33(7):637-48. PubMed ID: 15550883
    [Abstract] [Full Text] [Related]

  • 13. Non-invasive tests to predict fetal anemia in Kell-alloimmunized pregnancies.
    van Dongen H, Klumper FJ, Sikkel E, Vandenbussche FP, Oepkes D.
    Ultrasound Obstet Gynecol; 2005 Apr; 25(4):341-5. PubMed ID: 15736218
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Management of red blood cell alloimmunization in pregnancy.
    Ghesquière L, Garabedian C, Coulon C, Verpillat P, Rakza T, Wibaut B, Delsalle A, Subtil D, Vaast P, Debarge V.
    J Gynecol Obstet Hum Reprod; 2018 May; 47(5):197-204. PubMed ID: 29476829
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of D alloimmunization in pregnancy with plasmapheresis and intravenous immune globulin: case report.
    Fernández Alba JJ, León R, González-Macías C, Paz A, Prado F, Moreno LJ, Torrejón R.
    Transfus Apher Sci; 2014 Aug; 51(1):70-2. PubMed ID: 25312036
    [Abstract] [Full Text] [Related]

  • 19. Successful management of severe Kell alloimmunization in pregnancy with intravenous immune globulin.
    Patris M, Holoye A, Goldman D, De Coninck C, Colard M.
    Transfus Apher Sci; 2024 Apr; 63(2):103868. PubMed ID: 38238203
    [Abstract] [Full Text] [Related]

  • 20. Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions.
    Li L, Huang L, Luo G, Luo Y, Fang Q.
    Taiwan J Obstet Gynecol; 2017 Jun; 56(3):379-381. PubMed ID: 28600054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.